Phelan SM, Bauer KW, Bradley D, Bradley SM, Haller IV, Mundi MS, et al
Interaction with insulin secretion and resistance Semaglutide helps people with Type 2 diabetes by increasing insulin production
Geiger, B
The compound works by stimulating melanocortin receptors in the brain, specifically, the melanocortin-4 receptor (MC4R) in the hypothalamus, a center responsible for regulating sexual desire, dopamine, and other key neurotransmitter pathways involved in arousal and motivation
Identifying High-Risk Patients Pre-existing conditions that may increase NAION risk with GLP-1 use include: Diabetes, especially long-standing or poorly controlled Hypertension Hyperlipidemia Sleep apnea History of previous NAION in one eye Age is a significant factor, with individuals over 50 at higher risk
When you eat, your body releases GLP-1, which then acts on the brain, pancreas, and stomach